Journal
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 339, Issue 1-2, Pages 196-206Publisher
ELSEVIER
DOI: 10.1016/j.jns.2014.02.017
Keywords
Multiple sclerosis; Treatment; Relapses; Disability; MRI; Latin America; Clinical recommendations; Algorithm
Categories
Funding
- Novartis Latin America
- Novartis Canada Pharmaceuticals Inc.
Ask authors/readers for more resources
The Latin American MS Experts' Forum has developed practical recommendations on the initiation and optimization of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (RRMS). The recommendations reflect the unique epidemiology of MS and the clinical practice -environment in Latin American countries. Treatment response may be evaluated according to changes in relapses; progression, as assessed by the Expanded Disability Status Scale and the Timed 25-foot Walk; and lesion number on magnetic resonance imaging. Follow-up assessments are recommended every six months, or annually for stable patients. Cognitive function should be evaluated in all RRMS patients at baseline and annually thereafter. These recommendations are intended to assist clinicians in Latin America in developing a rational approach to treatment selection and sequencing for their RRMS patients. (C) 2014 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available